Fisher Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.45B | Buy |
|
|||||
|
2025
Q1 | $1.48B | Buy |
|
|||||
|
2024
Q4 | $718M | Buy |
|
|||||
|
2024
Q3 | $817M | Buy |
|
|||||
|
2024
Q2 | $776M | Buy |
|
|||||
|
2024
Q1 | $654M | Buy |
|
|||||
|
2023
Q4 | $631M | Buy |
|
|||||
|
2023
Q3 | $621M | Buy |
|
|||||
|
2023
Q2 | $639M | Buy |
|
|||||
|
2023
Q1 | $607M | Buy |
|
|||||
|
2022
Q4 | $590M | Sell |
|
|||||
|
2022
Q3 | $490M | Sell |
|
|||||
|
2022
Q2 | $1.41B | Buy |
|
|||||
|
2022
Q1 | $1.38B | Buy |
|
|||||
|
2021
Q4 | $1.17B | Buy |
|
|||||
|
2021
Q3 | $1.18B | Buy |
|
|||||
|
2021
Q2 | $1.13B | Buy |
|
|||||
|
2021
Q1 | $914M | Buy |
|
|||||
|
2020
Q4 | $892M | Buy |
|
|||||
|
2020
Q3 | $950M | Buy |
|
|||||
|
2020
Q2 | $895M | Buy |
|
|||||
|
2020
Q1 | $739M | Buy |
|
|||||
|
2019
Q4 | $816M | Buy |
|
|||||
|
2019
Q3 | $725M | Buy |
|
|||||
|
2019
Q2 | $657M | Buy |
|
|||||
|
2019
Q1 | $622M | Buy |
|
|||||
|
2018
Q4 | $568M | Buy |
|
|||||
|
2018
Q3 | $535M | Buy |
|
|||||
|
2018
Q2 | $459M | Buy |
|
|||||
|
2018
Q1 | $439M | Buy |
|
|||||
|
2017
Q4 | $414M | Buy |
|
|||||
|
2017
Q3 | $393M | Buy |
|
|||||
|
2017
Q2 | $378M | Buy |
|
|||||
|
2017
Q1 | $59.8M | Sell |
|
|||||
|
2016
Q4 | $53.3M | Sell |
|
|||||
|
2016
Q3 | $65M | Buy |
|
|||||
|
2016
Q2 | $10.2M | Buy |
|
|||||
|
2016
Q1 | $6.93M | Buy |
|
|||||
|
2015
Q4 | $7.52M | Buy |
|
|||||
|
2015
Q3 | $889K | Buy |
|